Tag: adolescent

AR101

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.
dupilumab

Study: Dupilumab Showed Positive Phase 3 Results in Adolescents with Inadequately...

"[dupilumab] blocks the IL-4/IL-13 pathway, which is emerging as a central driver of Type 2 allergic inflammation."

Study: Adolescents with More Support Take Fewer Food Allergy Risks

Adolescents and young adults fared better with strong support from their family, friends and school.

Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the...

We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

Connect with Us

39,099FansLike
742FollowersFollow
2,705FollowersFollow
5,519FollowersFollow
40SubscribersSubscribe